Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
184 studies found for:    "Wilms tumor"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor
Condition: Wilms Tumor
Intervention: Drug: Topotecan, Filgrastim (G-CSF), Pegfilgrastim
2 Recruiting Collaborative Wilms Tumour Africa Project
Condition: Wilms Tumour
Intervention:
3 Withdrawn National Wilm's Tumor Study Late Effects
Condition: Wilm's Tumor
Intervention: Other: none, screening only
4 Completed Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Wilms Tumor and Other Childhood Kidney Tumors
Intervention: Other: laboratory biomarker analysis
5 Active, not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Conditions: Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q;   Stage IV Wilms Tumor
Interventions: Drug: doxorubicin hydrochloride;   Drug: liposomal vincristine sulfate;   Procedure: conventional surgery;   Radiation: 3-dimensional conformal radiation therapy;   Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: etoposide
6 Completed Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
Conditions: Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Stage III Wilms Tumor
Intervention: Other: laboratory biomarker analysis
7 Recruiting Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
Conditions: Wilms' Tumor;   Aniridia
Interventions: Behavioral: Questionnaire;   Other: Blood specimen
8 Completed Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Conditions: Stage I Wilms Tumor;   Stage II Wilms Tumor;   Stage III Wilms Tumor
Interventions: Procedure: therapeutic conventional surgery;   Drug: vincristine sulfate;   Biological: dactinomycin;   Drug: doxorubicin hydrochloride;   Radiation: 3-dimensional conformal radiation therapy
9 Completed A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor
Conditions: Nephroblastoma;   Neuroblastoma
Intervention: Drug: IFN-alpha with retinoic acid
10 Recruiting Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Conditions: Ewing Sarcoma;   Rhabdomyosarcoma;   Wilms Tumor
Intervention: Radiation: Stereotactic Body Radiotherapy (SBRT)
11 Completed Gene Analysis in Studying Susceptibility to Wilms Tumor
Conditions: Recurrent Childhood Kidney Neoplasm;   Stage I Kidney Wilms Tumor;   Stage II Kidney Wilms Tumor;   Stage III Kidney Wilms Tumor;   Stage IV Kidney Wilms Tumor
Intervention: Other: Laboratory Biomarker Analysis
12 Completed Gene Expression Profiles to Categorize Wilms Tumors
Conditions: Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Stage I Wilms Tumor;   Stage II Wilms Tumor;   Stage III Wilms Tumor;   Stage IV Wilms Tumor;   Stage V Wilms Tumor
Intervention: Other: laboratory biomarker analysis
13 Completed Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: DNA analysis;   Genetic: nucleic acid amplification;   Other: diagnostic laboratory biomarker analysis;   Other: medical chart review
14 Unknown  WT1 Peptid Vaccination in Carcinomas
Condition: WT1 Expressing Carcinoma
Intervention: Biological: WT1 126-134 peptide
15 Completed Biomarkers in Urine Samples From Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: proteomic profiling;   Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis;   Other: medical chart review
16 Completed Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Condition: Kidney Cancer
Interventions: Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Genetic: loss of heterozygosity analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis
17 Completed Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases
Conditions: Denys-Drash Syndrome;   Frasier Syndrome;   Nephrotic Syndrome;   Wilms Tumor
Intervention:
18 Active, not recruiting Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Conditions: Adult Renal Wilms Tumor;   Beckwith-Wiedemann Syndrome;   Childhood Renal Wilms Tumor;   Diffuse Hyperplastic Perilobar Nephroblastomatosis;   Hemihypertrophy;   Stage I Renal Wilms Tumor;   Stage II Renal Wilms Tumor;   Stage III Renal Wilms Tumor;   Stage IV Renal Wilms Tumor;   Stage V Renal Wilms Tumor
Interventions: Biological: Dactinomycin;   Drug: Doxorubicin Hydrochloride;   Drug: Vincristine Sulfate;   Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Etoposide Phosphate;   Radiation: Radiation Therapy;   Procedure: Therapeutic Conventional Surgery;   Procedure: Adjuvant Therapy;   Procedure: Neoadjuvant Therapy
19 Unknown  Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: vincristine sulfate;   Procedure: conventional surgery
20 Completed Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Kidney Cancer
Interventions: Genetic: gene expression analysis;   Genetic: proteomic profiling;   Genetic: reverse transcriptase-polymerase chain reaction;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: spectroscopy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.